BETAPHARMA Trademark

Trademark Overview

On Friday, September 27, 2013, a trademark application was filed for BETAPHARMA with the United States Patent and Trademark Office. The USPTO has given the BETAPHARMA trademark a serial number of 86076901. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, July 22, 2025. This trademark is owned by Beta Pharma, Inc. The BETAPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; medical research and scientific research information in the field of pharmaceuticals and clinical trials
betapharma

General Information

Serial Number86076901
Word MarkBETAPHARMA
Filing DateFriday, September 27, 2013
Status800 - REGISTERED AND RENEWED
Status DateTuesday, July 22, 2025
Registration Number4741673
Registration DateTuesday, May 26, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2015

Trademark Statements

Goods and ServicesPharmaceutical research and development; medical research and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 7, 2013
Primary Code042
First Use Anywhere DateFriday, January 26, 2001
First Use In Commerce DateFriday, January 26, 2001

Trademark Owner History

Party NameBeta Pharma, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameBeta Pharma, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameBeta Pharma, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Tuesday, October 1, 2013NEW APPLICATION ENTERED
Tuesday, July 29, 2014NON-FINAL ACTION WRITTEN
Monday, October 7, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 11, 2014ASSIGNED TO EXAMINER
Tuesday, January 14, 2014NON-FINAL ACTION WRITTEN
Tuesday, January 14, 2014NON-FINAL ACTION E-MAILED
Tuesday, January 14, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 24, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 2, 2014ASSIGNED TO LIE
Tuesday, July 8, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 8, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 29, 2014NON-FINAL ACTION E-MAILED
Tuesday, July 29, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 8, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 15, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 24, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 2, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 10, 2015PUBLISHED FOR OPPOSITION
Saturday, July 17, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 25, 2025TEAS SECTION 8 & 9 RECEIVED
Tuesday, July 22, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, July 22, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, July 22, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, July 22, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 26, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, May 26, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, March 11, 2021TEAS SECTION 8 & 15 RECEIVED
Saturday, July 17, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, July 17, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, May 26, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

betapharma research pharmaceuticals clinical trials field scientific development medical pharmaceutical information